Clinical trial
Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study…
NCT00231231 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00231231 |
|---|---|
| Title | Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS) |
| Official title | Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS) |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carotid Artery Disease |
| Intervention type | Device |
| Interventions | -PRECISE Nitinol Stent System (5F, 5.5F and 6F), ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW) |
| Enrollment | 1,500 |
| Start date | Sep 1, 2004 |
| Completion | Nov 1, 2006 |
| First posted | Oct 4, 2005 |
| Last update posted | Jul 20, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: